Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
14.00
-0.75 (-5.08%)
Dec 11, 2025, 10:16 AM EST
145.61%
Market Cap56.30M
Revenue (ttm)n/a
Net Income (ttm)-39.71M
Shares Out3.82M
EPS (ttm)-14.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume126
Average Volume8,804
Open14.78
Previous Close14.75
Day's Range14.00 - 14.78
52-Week Range3.90 - 52.00
Beta0.71
RSI52.03
Earnings DateMar 27, 2026

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.